Illuminating Substrate Preferences of Promiscuous F420H2-Dependent Dehydroamino Acid Reductases with 4-Track mRNA Display

被引:0
作者
Vinogradov, Alexander A. [1 ]
Bashiri, Ghader [2 ]
Suga, Hiroaki [1 ]
机构
[1] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 1130033, Japan
[2] Univ Auckland, Sch Biol Sci, Lab Microbial Biochem & Biotechnol, Auckland 92019, New Zealand
基金
日本学术振兴会;
关键词
RIBOSOMALLY SYNTHESIZED PEPTIDES; D-ALANINE; PHAGE; BIOSYNTHESIS; SPECIFICITY; DERIVATIVES; ATTACHMENT; SELECTION; NISIN; PROCM;
D O I
10.1021/jacs.4c11013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Stereoselective reduction of dehydroamino acids is a common biosynthetic strategy to introduce d-amino acids into peptidic natural products. The reduction, often observed during the biosynthesis of lanthipeptides, is performed by dedicated dehydroamino acid reductases (dhAARs). Enzymes from the three known dhAAR families utilize nicotinamide, flavin, or F420H2 coenzymes as hydride donors, and little is known about the catalysis performed by the latter family proteins. Here, we perform a bioinformatics-guided identification and large-scale in vitro characterization of five F420H2-dependent dhAARs. We construct an mRNA display-based pipeline for ultrahigh throughput substrate specificity profiling of the enzymes. The pipeline relies on a 4-track selection strategy to deliver large quantities of clean data, which were leveraged to build accurate substrate fitness models. Our results identify a remarkably promiscuous enzyme, referred to as MaeJC, that is capable of installing d-Ala residues into arbitrary substrates with minimal recognition requirements. We integrate MaeJC into a thiopeptide biosynthetic pathway to produce d-amino acids-containing thiopeptides, demonstrating the utility of MaeJC for the programmable installation of d-amino acids in ribosomal peptides.
引用
收藏
页码:31124 / 31136
页数:13
相关论文
共 84 条
  • [1] Accurate structure prediction of biomolecular interactions with AlphaFold 3
    Abramson, Josh
    Adler, Jonas
    Dunger, Jack
    Evans, Richard
    Green, Tim
    Pritzel, Alexander
    Ronneberger, Olaf
    Willmore, Lindsay
    Ballard, Andrew J.
    Bambrick, Joshua
    Bodenstein, Sebastian W.
    Evans, David A.
    Hung, Chia-Chun
    O'Neill, Michael
    Reiman, David
    Tunyasuvunakool, Kathryn
    Wu, Zachary
    Zemgulyte, Akvile
    Arvaniti, Eirini
    Beattie, Charles
    Bertolli, Ottavia
    Bridgland, Alex
    Cherepanov, Alexey
    Congreve, Miles
    Cowen-Rivers, Alexander I.
    Cowie, Andrew
    Figurnov, Michael
    Fuchs, Fabian B.
    Gladman, Hannah
    Jain, Rishub
    Khan, Yousuf A.
    Low, Caroline M. R.
    Perlin, Kuba
    Potapenko, Anna
    Savy, Pascal
    Singh, Sukhdeep
    Stecula, Adrian
    Thillaisundaram, Ashok
    Tong, Catherine
    Yakneen, Sergei
    Zhong, Ellen D.
    Zielinski, Michal
    Zidek, Augustin
    Bapst, Victor
    Kohli, Pushmeet
    Jaderberg, Max
    Hassabis, Demis
    Jumper, John M.
    [J]. NATURE, 2024, 630 (8016) : 493 - 500
  • [2] Outwitting EF-Tu and the ribosome: translation with D-amino acids
    Achenbach, John
    Jahnz, Michael
    Bethge, Lucas
    Paal, Krisztina
    Jung, Maria
    Schuster, Maja
    Albrecht, Renate
    Jarosch, Florian
    Nierhaus, Knud H.
    Klussmann, Sven
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (12) : 5687 - 5698
  • [3] Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
    Arnison, Paul G.
    Bibb, Mervyn J.
    Bierbaum, Gabriele
    Bowers, Albert A.
    Bugni, Tim S.
    Bulaj, Grzegorz
    Camarero, Julio A.
    Campopiano, Dominic J.
    Challis, Gregory L.
    Clardy, Jon
    Cotter, Paul D.
    Craik, David J.
    Dawson, Michael
    Dittmann, Elke
    Donadio, Stefano
    Dorrestein, Pieter C.
    Entian, Karl-Dieter
    Fischbach, Michael A.
    Garavelli, John S.
    Goeransson, Ulf
    Gruber, Christian W.
    Haft, Daniel H.
    Hemscheidt, Thomas K.
    Hertweck, Christian
    Hill, Colin
    Horswill, Alexander R.
    Jaspars, Marcel
    Kelly, Wendy L.
    Klinman, Judith P.
    Kuipers, Oscar P.
    Link, A. James
    Liu, Wen
    Marahiel, Mohamed A.
    Mitchell, Douglas A.
    Moll, Gert N.
    Moore, Bradley S.
    Mueller, Rolf
    Nair, Satish K.
    Nes, Ingolf F.
    Norris, Gillian E.
    Olivera, Baldomero M.
    Onaka, Hiroyasu
    Patchett, Mark L.
    Piel, Joern
    Reaney, Martin J. T.
    Rebuffat, Sylvie
    Ross, R. Paul
    Sahl, Hans-Georg
    Schmidt, Eric W.
    Selsted, Michael E.
    [J]. NATURAL PRODUCT REPORTS, 2013, 30 (01) : 108 - 160
  • [4] Thiopeptide antibiotics
    Bagley, MC
    Dale, JW
    Merritt, EA
    Xiong, A
    [J]. CHEMICAL REVIEWS, 2005, 105 (02) : 685 - 714
  • [5] Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate binding
    Bashiri, Ghader
    Squire, Christopher J.
    Moreland, Nicole J.
    Baker, Edward N.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) : 17531 - 17541
  • [7] Metabolic Engineering of Cofactor F420 Production in Mycobacterium smegmatis
    Bashiri, Ghader
    Rehan, Aisyah M.
    Greenwood, David R.
    Dickson, James M. J.
    Baker, Edward N.
    [J]. PLOS ONE, 2010, 5 (12):
  • [8] CONFORMATIONAL-ANALYSIS OF CYCLIC HEXAPEPTIDES CONTAINING THE D-PRO-L-PRO SEQUENCE TO FIX BETA-TURN POSITIONS
    BEAN, JW
    KOPPLE, KD
    PEISHOFF, CE
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (13) : 5328 - 5334
  • [9] Benjdia A, 2017, NAT CHEM, V9, P698, DOI [10.1038/NCHEM.2714, 10.1038/nchem.2714]
  • [10] Chimeric Leader Peptides for the Generation of Non-Natural Hybrid RiPP Products
    Burkhart, Brandon J.
    Kakkar, Nidhi
    Hudson, Graham A.
    van der Donk, Wilfred A.
    Mitchell, Douglas A.
    [J]. ACS CENTRAL SCIENCE, 2017, 3 (06) : 629 - 638